EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study

Masato Habuka, Sahoko Otsuka, Kazunori Satokata, Asa Ogawa, Suguru Yamamoto

Journal of Clinical Medicine Research · 2026-11 · 18 (11) · 815-822

DOI: 10.14740/jocmr6733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine Research, 2026-11. Verfasst von Masato Habuka und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Habuka, M., Otsuka, S., Satokata, K., Ogawa, A., & Yamamoto, S. (2026). Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study. Journal of Clinical Medicine Research, 18(11), 815-822. https://doi.org/10.14740/jocmr6733

Vancouver

Habuka M, Otsuka S, Satokata K, Ogawa A, Yamamoto S. Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study. Journal of Clinical Medicine Research. 2026;18(11):815-822. doi:10.14740/jocmr6733

BibTeX
@article{Habuka2026,
  author = {Habuka, Masato and Otsuka, Sahoko and Satokata, Kazunori and Ogawa, Asa and Yamamoto, Suguru},
  title = {Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study},
  journal = {Journal of Clinical Medicine Research},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {815--822},
  doi = {10.14740/jocmr6733}
}
Kostenlos starten →